8 / 21
Page 71
allied
academies
International Surgery and Ortho Conference
October 25-26, 2017 | Toronto, Canada
Case Rep Surg Invasive Proced 2017 | Volume 1 Issue 3
R
heumatoid arthritis is a systemic inflammatory disorder
affecting many organs (skin, joints, lung and liver) but,
commonly affecting in synovial fluid of joints. It affects 1%
of the world population. It has no known causative factor
despite the many possible theories. It is one of the causes
of disability. In one hand, developed countries, because of
DMRADS and ‘biologics’ the treatment option is expanded
and the quality of life of these patients improved. On the
other hand, in developing countries, like Ethiopia, the
options of treatment pause on only NSAIDs and steroids.
NSAIDs and steroids may decrease the progression of the
inflammatory response but do not halt the inflammatory
process. In Ethiopia, especially in rural areas, a lot people
are affected by this disease. In addition, though the disease
usually affects those with age 40-50 years, in Ethiopia, we
found many patients with the age of 20–30 yrs. In Delgi
Hospital, it is the 8th leading cause of hospital visit in
outpatient departments in above 5 years patients and it
accounts 6.59% of patients seen between March 30 and
June 27, 2016 G.C. Despite the above figure, the treatment
includes only NSAIDs and steroids. Most of these patients will
subsequently have follow up in the hospital. The progression
slows down, but after 15-20 years they eventually develop
permanent disability. Introducing DMRADs and ‘biologics’
in developing countries like Ethiopia, may help reduce rate
of disabilities, thereby saving the working population which
may contribute to saving the countries economy.
e:
brookdemissietekle@gmail.comWhat causes rheumatoid arthritis?
Brook Demissie
St. Peter Specialized Hospital, Ethiopia